Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Liesbeth C. De Boer"'
Autor:
Bert Van Klingeren, Ad P.M. Van Der Meijden, Peter A. Steerenberg, Frans M.J. Debruyne, Wim H. de Jong, Liesbeth C. De Boer
Publikováno v:
Journal of Urology. 146:444-446
Intravesical treatment with Bacillus Calmette-Guérin is an established treatment of carcinoma in situ and an effective prophylaxis for the prevention of recurrence of transitional cell carcinoma. During instillation therapy oral antibiotics may be u
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::761dfdb38a2a9c484b12c7255e470d8f
https://doi.org/10.1016/s0022-5347(17)37821-7
https://doi.org/10.1016/s0022-5347(17)37821-7
Autor:
D. H. J. Schamhart, Peter A. Steerenberg, P. C. N. Vos, Liesbeth C. De Boer, Karl-Heinz Kurth, Theo M. de Reijke
Publikováno v:
The Journal of urology. 151(3)
Immunotherapy with intravesical instillation of bacillus Calmette-Guérin (BCG) is an effective treatment for superficial bladder carcinoma. In the present study the BCG-induced immunological reaction in the guinea pig (PPD skin test, bladder wall in
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c3b1e3a49888cb0df880dc454e22e906
https://pubmed.ncbi.nlm.nih.gov/7508528
https://pubmed.ncbi.nlm.nih.gov/7508528
Autor:
Bert Van Klingeren, Wim H. de Jong, Frans M.J. Debruyne, Ad P.M. Van Der Meijden, Peter A. Steerenberg, E. Joost Ruitenberg, Anneke Elgersma, Liesbeth C. De Boer
Publikováno v:
The Journal of urology. 148(5)
At present, isoniazid (INH) is being used prophylactically to reduce the side effects of intravesical BCG therapy for superficial bladder cancer, although it is not clear whether or not this reduces the antitumor efficacy of BCG. In this study the im
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::76a8a159a55f2cffed2476cd9400b3cd
https://pubmed.ncbi.nlm.nih.gov/1433571
https://pubmed.ncbi.nlm.nih.gov/1433571